| 0 (0%) | 11-30 07:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.53 | 1-year : | 4.01 |
| Resists | First : | 3.02 | Second : | 3.44 |
| Pivot price | 2.59 |
|||
| Supports | First : | 2.35 | Second : | 1.96 |
| MAs | MA(5) : | 2.5 |
MA(20) : | 2.63  |
| MA(100) : | 3.3 |
MA(250) : | 4.93 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 33.3 |
D(3) : | 22.1 |
| RSI | RSI(14): 46.2 |
|||
| 52-week | High : | 9.84 | Low : | 1.94 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CMMB ] has closed below upper band by 43.1%. Bollinger Bands are 44.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.55 - 2.56 | 2.56 - 2.57 |
| Low: | 2.39 - 2.4 | 2.4 - 2.41 |
| Close: | 2.51 - 2.53 | 2.53 - 2.55 |
Sat, 29 Nov 2025
How supply chain issues affect CMMB stock - Quarterly Market Summary & Risk Adjusted Buy/Sell Alerts - moha.gov.vn
Fri, 28 Nov 2025
Can CMMB stock weather global recession - 2025 Top Decliners & Stepwise Swing Trade Plans - moha.gov.vn
Mon, 24 Nov 2025
Chemomab (Nasdaq: CMMB) to Present at Oppenheimer Rare Disease Summit Dec. 11, 2025 - Stock Titan
Thu, 20 Nov 2025
Chemomab Therapeutics (Nasdaq: CMMB) Plans Single Nebokitug Phase 3 Trial in PSC - Stock Titan
Wed, 19 Nov 2025
CMMB Vision Holdings Announces Rights Issue to Raise HK$174.34 Million - TipRanks
Sun, 21 Sep 2025
Join CMMB Kenya in Transforming Healthcare for Vulnerable Communities - 3 Roles Available - Global South Opportunities
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 5 (M) |
| Shares Float | 322 (M) |
| Held by Insiders | 16.7 (%) |
| Held by Institutions | 13.1 (%) |
| Shares Short | 31 (K) |
| Shares Short P.Month | 142 (K) |
| EPS | -2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.87 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -61.8 % |
| Return on Equity (ttm) | -120.2 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -2.43 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -14 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -1.31 |
| PEG Ratio | 0 |
| Price to Book value | 1.39 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.95 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|